Finally, FBXO6 has been reported to play a role in cell cycle control, inactivating S-phase and spindle checkpoints, and might contribute to increase tumor cell resistance to certain anticancer drugs [29,30]. This evidence concerns the gene FBXO6 and neoplasm.